azomycin has been researched along with Adenocarcinoma in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (46.34) | 18.7374 |
1990's | 8 (19.51) | 18.2507 |
2000's | 5 (12.20) | 29.6817 |
2010's | 9 (21.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biemans, R; Dubois, LJ; Lambin, P; Lieuwes, NG; Marcus, D; Niemans, R; Spiegelberg, L; Theys, J; van Hoof, SJ; Verhaegen, F; Yaromina, A | 1 |
Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 1 |
Brans, B; Ceelen, W; De Vlieghere, E; De Vos, F; De Wever, O; Descamps, B; Goethals, I; Kersemans, K; Melsens, E; Pattyn, P; Vanhove, C | 1 |
Ager, C; Ai, M; Balasubramanyam, S; Bartkowiak, T; Budhani, P; Curran, MA; Jaiswal, AR; Jayaprakash, P; Li, N; Liu, A; Nicholas, C; Ning, J; Shah, K; Sheng, J; Sun, Y; Wang, G; Zal, A; Zal, T | 1 |
Bailey, KM; Baker, AF; Cornnell, HH; Gillies, RJ; Hart, CP; Ibrahim-Hashim, A; Leos, R; Martinez, GV; Wojtkowiak, JW; Zhang, X | 1 |
Ahmad, Z; Chen, X; Lv, S; Shah, A; Tang, Z | 1 |
Berbée, M; Claessens, A; Dubois, LJ; Erdkamp, FL; Lambin, P; Larue, RT; Nap, M; Panth, KM; Peeters, SG; Schreurs, WM; Sosef, MN; Van De Voorde, L; van Elmpt, WJ; Warmerdam, FA | 1 |
Humm, JL; Li, GC; Li, XF; Ling, CC; Russell, J; Sun, X; Urano, M; Xing, L | 1 |
Cho, H; Koutcher, JA; Li, XF; Ling, CC; Lupu, ME; Russell, J; Yang, KM | 1 |
An, H; Engenhart-Cabillic, R; Eul, BG; Fokas, E; Hänze, J; Heverhagen, JT; Kamlah, F; Keil, B; Lang, N; Rose, F | 1 |
Bachtiary, B; Dimopoulos, J; Dudczak, R; Georg, D; Karanikas, G; Kletter, K; Kommata, S; Lukic, D; Pötter, R; Schmid, MP; Schuetz, M | 1 |
Bennewith, KL; Durand, RE | 1 |
Begg, AC; De Schutter, H; Debucquoy, A; Ectors, N; Geboes, K; Goethals, L; Haustermans, KM; McBride, WH; Penninckx, F; Perneel, C | 1 |
Blanke, G; Luscher, G; Streffer, C; Tamulevicius, P | 1 |
Byhardt, RW; Cox, JD; Greenberg, M; Komaki, R | 1 |
Begg, AC; Terry, NH | 1 |
Brown, DM; Goldfeder, A | 1 |
Banerjee, R; Goldfeder, A; Mitra, J | 1 |
Carella, RJ; Concannon, JP; Perez, CA; Phillips, TL; Simpson, JR | 1 |
Dische, S; Minchinton, A; Rich, TA; Saunders, MI; Stratford, MR | 1 |
Courtenay, VD; Mills, J; Peacock, JH; Rose, CM; Spooner, D; Stephens, TC | 1 |
Breur, K; Haveman, J; van den Hoeven, H; van der Schueren, E; Wondergem, J | 1 |
Guichard, M; Hodgkiss, RJ; Stern, S | 1 |
Hodgkiss, RJ; Webster, L; Wilson, GD | 2 |
Begg, AC; Geboes, K; Haustermans, K; Hofland, I; Raleigh, J; Van de Pavert, L; Varia, M | 1 |
Davies, RW; Hall, WS | 1 |
Bleehen, NM; Owen, LN; White, RA; Workman, P | 1 |
Berger, A; Brown, DM; Goldfeder, A | 1 |
Kauffman, SL; Rostom, AY; Steel, GG | 1 |
Buswell, L; Coleman, CN; Noll, L; Riese, N; Rose, MA | 1 |
Beckman, W; Gill, M; Joseph, AP; Kwock, L; McMurry, HL; Raleigh, JA | 1 |
Allen, PS; Franko, AJ; Kelly, DA; Raleigh, JA; Trimble, LA | 1 |
Guichard, ME; Lespinasse, F; Taghian, A | 1 |
Bleehen, NM; Newman, HF; Smithen, CE; Ward, R; Workman, P | 1 |
George, KC; Pelzer, T; Streffer, C | 1 |
Luscher, G; Streffer, C; Tamulevicius, P | 1 |
Egolf, RA; Fitzpatrick, DA; Heindel, ND; Walton, H | 1 |
Bleehen, NM; Newman, HF; Workman, P | 1 |
Noker, PE; Simpson-Herren, L; Wagoner, SD | 1 |
Bryan, GT; Cohen, SM; Crovetti, AJ; Ertürk, E; Von Esch, AM | 1 |
3 trial(s) available for azomycin and Adenocarcinoma
Article | Year |
---|---|
A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
Topics: Adenocarcinoma; Cell Hypoxia; Chemoradiotherapy, Adjuvant; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Nitroimidazoles; Phosphoramide Mustards; Positron-Emission Tomography; Preoperative Care; Survival Analysis; Treatment Outcome | 2016 |
Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.
Topics: Adaptation, Biological; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Nitroimidazoles; Periodicity; Pilot Projects; Positron-Emission Tomography; Radiography; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Uterine Cervical Neoplasms | 2010 |
The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
Topics: Adenocarcinoma; Combined Modality Therapy; Drug Evaluation; Etanidazole; Humans; Male; Nitroimidazoles; Peripheral Nervous System Diseases; Prostatic Neoplasms; Radiation-Sensitizing Agents | 1992 |
38 other study(ies) available for azomycin and Adenocarcinoma
Article | Year |
---|---|
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Esophageal Neoplasms; Female; Humans; Male; Mice; Nitroimidazoles; Phosphoramide Mustards; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck | 2019 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
Hypoxia imaging with
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Cell Line, Tumor; Esophageal Neoplasms; Humans; Mice; Mice, Nude; Nimorazole; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2018 |
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Cell Line, Tumor; Immunotherapy; Male; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms, Experimental; Nitroimidazoles; Phosphoramide Mustards; Prostatic Neoplasms; T-Lymphocytes | 2018 |
Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Circulation; Cell Hypoxia; Cell Line, Tumor; Drug Synergism; Female; Humans; Hydralazine; Hydrogen-Ion Concentration; Mice; Nitroimidazoles; Pancreatic Neoplasms; Phosphoramide Mustards; Prodrugs; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2014 |
Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Survival; Doxorubicin; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Hypoxia; MCF-7 Cells; Micelles; Nanoparticles; Nitroimidazoles; Polyglutamic Acid; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Tumor Microenvironment | 2016 |
Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Cell Hypoxia; Colorectal Neoplasms; Etanidazole; Female; Hydrocarbons, Fluorinated; Hyperthermia, Induced; Immunohistochemistry; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2008 |
Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.
Topics: Adenocarcinoma; Animals; Atrasentan; Colonic Neoplasms; Combined Modality Therapy; Etanidazole; Gadolinium DTPA; HT29 Cells; Humans; Hydrocarbons, Fluorinated; Hypoxia; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Nitroimidazoles; Perfusion; Pyrrolidines; Radiation-Sensitizing Agents; Radiotherapy; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzimidazoles; Biomarkers; Caspase 3; Cell Hypoxia; Contrast Media; Gadolinium; Glucose Transporter Type 1; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Time Factors; Transplantation, Heterologous | 2010 |
Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Female; Flow Cytometry; Humans; Mice; Mice, SCID; Nitroimidazoles; Oxygen; Partial Pressure; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2004 |
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Carbonic Anhydrases; Cell Hypoxia; Colonic Neoplasms; ErbB Receptors; Female; Humans; Idoxuridine; Male; Microcirculation; Middle Aged; Nitroimidazoles; Observer Variation; Rectal Neoplasms; Vascular Endothelial Growth Factor A | 2006 |
The effects of radiosensitizers on intermediary metabolism in vivo.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adenocarcinoma; Animals; Dihydroxyacetone Phosphate; Etanidazole; Glycerophosphates; Hydroxybutyrates; Lactates; Liver; Male; Mice; Mice, Inbred Strains; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pyruvates; Radiation-Sensitizing Agents | 1984 |
Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Oropharynx; Pharyngeal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies | 1980 |
Modification of stromal radiosensitivity by misonidazole and WR-2721.
Topics: Adenocarcinoma; Amifostine; Animals; Connective Tissue; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance | 1983 |
Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Diathermy; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
Topics: Adenocarcinoma; Animals; Chromosome Aberrations; Crossing Over, Genetic; Female; Hot Temperature; Karyotyping; Mammary Neoplasms, Experimental; Mice; Microwaves; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiotherapy Dosage; Sister Chromatid Exchange; Time Factors; X-Rays | 1983 |
Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Radiotherapy; Radiotherapy Dosage | 1982 |
A serial study of the concentration of misonidazole in human tumors correlated with histologic structure.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Female; Humans; Male; Misonidazole; Necrosis; Nitroimidazoles; Radiotherapy Dosage | 1981 |
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pancreatic Neoplasms; Transplantation, Heterologous | 1981 |
The influence of misonidazole on the radiation response of murine tumors of different size: possible artifacts caused by pentobarbital sodium anesthesia.
Topics: Adenocarcinoma; Anesthesia; Animals; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Pentobarbital; Radiation-Protective Agents | 1981 |
Comparison of two techniques for detecting tumour hypoxia: a fluorescent immunochemical method and an in vitro colony assay.
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Cell Hypoxia; Cell Survival; Cesium Radioisotopes; DNA Damage; DNA, Neoplasm; Drug Combinations; Emulsions; Female; Fluorescent Antibody Technique, Indirect; Fluorocarbons; Humans; Hydrocarbons, Brominated; Mammary Neoplasms, Animal; Mice; Mice, Nude; Niacinamide; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Rectal Neoplasms; Theophylline; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Hypoxia; Mice; Neoplasms, Experimental; Nitroimidazoles; Sarcoma, Experimental; Theophylline | 1998 |
Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP).
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Mammary Neoplasms, Experimental; Mice; Nitroimidazoles; Oxygen; Respiration; Sarcoma, Experimental; Theophylline | 1997 |
Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.
Topics: Adenocarcinoma; Blood Vessels; Carcinoma, Squamous Cell; Cell Hypoxia; Diffusion; Esophageal Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Nitroimidazoles; Observer Variation; Radiation-Sensitizing Agents; Rectal Neoplasms; Reproducibility of Results; Uterine Cervical Neoplasms | 2000 |
Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
Topics: Adenocarcinoma; Animals; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Skin; Time Factors | 1978 |
The penetration of misonidazole into spontaneous canine tumours.
Topics: Adenocarcinoma; Anesthesia, Intravenous; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Female; Fibrosarcoma; Half-Life; Lymphoma, Non-Hodgkin; Male; Mammary Glands, Animal; Meningioma; Misonidazole; Neoplasms; Nitroimidazoles; Osteosarcoma; Pentobarbital | 1979 |
Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
Topics: Adenocarcinoma; Animals; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Radiation Tolerance; Remission, Spontaneous; Time Factors; X-Rays | 1979 |
Influence of misonidazole on the incidence of radiation-induced intestinal tumours in mice.
Topics: Adenocarcinoma; Animals; Cecal Neoplasms; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasms, Radiation-Induced; Nitroimidazoles; Rectal Neoplasms | 1978 |
Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry.
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Evaluation Studies as Topic; Immunohistochemistry; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats | 1992 |
Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors.
Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Cell Hypoxia; Female; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Tritium | 1991 |
Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Topics: Adenocarcinoma; Animals; Cell Survival; Drug Synergism; Etanidazole; Female; Humans; Melanoma; Mice; Mice, Nude; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rectal Neoplasms | 1991 |
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Radiation-Sensitizing Agents; Stereoisomerism | 1991 |
Combined effects of X rays, Ro 03-8799, and hyperthermia on growth, necrosis, and cell proliferation in a mouse tumor.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1989 |
Effects on intermediary metabolism in mouse tissues by Ro-03-8799.
Topics: Adenocarcinoma; Animals; Body Temperature; Brain; Glucose; Glucose-6-Phosphatase; Ketone Bodies; Lipid Metabolism; Liver; Liver Glycogen; Male; Mice; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1987 |
Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
Topics: Adenocarcinoma; Cell Line; Cell Survival; Colorectal Neoplasms; Humans; In Vitro Techniques; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |
A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
Topics: Adenocarcinoma; Drug Combinations; Drug Evaluation; Etanidazole; Humans; Melanoma; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.
Topics: Adenocarcinoma; Animals; Female; Lissamine Green Dyes; Mammary Neoplasms, Experimental; Melphalan; Metronidazole; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1987 |
Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds.
Topics: Adenocarcinoma; Animals; Benzene Derivatives; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Kidney Neoplasms; Leukemia, Experimental; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Nitroimidazoles; Rats | 1973 |